Delivery Order SPE2DB22D3102-SPE2DB25FK9CH
Award Date
11/21/24
Potential Completion Date
11/22/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,376.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with an ultimate completion date of October 31, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,354.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with an ultimate completion date of October 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $5,485.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a performance period ending on November 8, 2024. The contract is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,546.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a performance period through November 19, 2024. This award is issued as a Delivery Order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,975.60, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award, valued at $1,150.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a performance period through March 14, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,906.93, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,907.26, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $5,448.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2024 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $3,704.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, and has a completion date of June 25, 2024. The contract is a delivery order, with a firm fixed-price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...